AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
16.88
+1.03 (6.50%)
Jan 21, 2025, 4:00 PM EST - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 42.67, with a low estimate of 20 and a high estimate of 80. The average target predicts an increase of 152.78% from the current stock price of 16.88.
Analyst Consensus: Buy
* Price targets were last updated on Dec 19, 2024.
Analyst Ratings
The average analyst rating for AnaptysBio stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $66 → $36 | Buy | Maintains | $66 → $36 | +113.27% | Dec 19, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $30 → $20 | Hold | Maintains | $30 → $20 | +18.48% | Dec 18, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $56 → $40 | Buy | Maintains | $56 → $40 | +136.97% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $90 → $36 | Strong Buy | Maintains | $90 → $36 | +113.27% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
Financial Forecast
Revenue This Year
56.47M
from 17.16M
Increased by 229.13%
Revenue Next Year
32.55M
from 56.47M
Decreased by -42.36%
EPS This Year
-6.21
from -6.08
EPS Next Year
-5.86
from -6.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.4M | 72.3M | 107.3M | |||
| Avg | 56.5M | 32.5M | 41.1M | |||
| Low | 47.2M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 292.9% | 28.1% | 229.7% | |||
| Avg | 229.1% | -42.4% | 26.3% | |||
| Low | 175.1% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -5.99 | -3.89 | -2.86 | |||
| Avg | -6.21 | -5.86 | -5.52 | |||
| Low | -6.40 | -7.21 | -8.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.